Search results
Raleigh Capital Management Inc. Sells 2,270 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 6 hours agoRaleigh Capital Management Inc. cut its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 3.4% in the fourth quarter, according to the company in its most recent disclosure ...
Pfizer Inc. (NYSE:PFE) Position Increased by V Square Quantitative Management LLC
ETF DAILY NEWS· 7 hours agoV Square Quantitative Management LLC increased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 260.1% in the 4th quarter, according to the company in its ...
Flagship taps startup to hunt for obesity drugs that might interest Pfizer
BioPharma Dive via Yahoo Finance· 4 days agoThe venture firm will work with ProFound Therapeutics to “rapidly surface” protein drug candidates...
Pfizer (NYSE:PFE) Stock Price Down 0.9%
ETF DAILY NEWS· 1 day agoPfizer Inc. (NYSE:PFE – Get Free Report) was down 0.9% during trading on Thursday . The company traded as low as $27.20 and last traded at $27.41. Approximately 11,513,196 ...
Is It Too Late to Buy Pfizer Stock?
Motley Fool via Yahoo Finance· 2 days agoAre Pfizer's (NYSE: PFE) best days behind it? If the stock's critics are to be believed, the answer is an emphatic "yes, obviously," with issues like its...
Voisard Asset Management Group Inc. Takes $86,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 1 day agoVoisard Asset Management Group Inc. bought a new stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to the company in its most recent ...
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
Motley Fool via Yahoo Finance· 15 hours agoA handful of terrific healthcare stocks have fallen more than 25% from the peaks they set less than...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks via Yahoo Finance· 3 days agoPfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Investor's Business Daily· 3 days agoSarepta stock jumped Thursday after Pfizer's rival gene therapy for Duchenne muscular dystrophy...
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 4 days agoSome say the art of investing is the ability of catching falling knives. Pfizer Inc. (NYSE:PFE) shares have sold off in 2023 and represent an attractive...